Escolar Documentos
Profissional Documentos
Cultura Documentos
ELISA Kit
Cat. No. E88-500
Components Supplied
HRP Solution A, 12 ml
TMB Substrate, 12 ml
Stop Solution, 12 ml
Introduction
This enzyme linked immunosorbent assay (ELISA) is for the measurement of
Human ADAMTS13 in plasma as a percentage of normal reference plasma. This
kit contains sufficient components to quantitate Human ADAMTS13 in up to 40
samples, tested in duplicate.
Background
ADAMTS13: A Disintegrin-like And Metalloprotease with ThromboSpondin
type 1 repeats is a von Willebrand factor-cleaving metalloproteinase. The level
of ADAMTS13 in normal plasma is estimated 900 ng/ml.1 Deficiency of
ADAMTS13 results in the development of clinical entity Thrombotic
Thrombocytopenic Purpura (TTP) and may play a role in Hemolytic Uremic
Syndrome. Von Willebrands Factor is synthesized by endothelial cells and
stored in the sub-endothelial space as very large multimeric structures
(unusually large vWf: ULVWf). These ULVWf avidly bind platelets when they
are exposed in the setting of endothelial disruption and lead to platelet clumping
and closure of the endothelial rent. Any ULVWf that escapes into circulation is
rapidly degraded by ADAMTS13. Deficiency of ADAMTS13 (congenital or
acquired) leads to the accumulation of ULVWf in the plasma with resultant
systemic platelet aggregation and clumping. This leads to the clinical syndrome
of TTP characterized by thrombocytopenia, microangiopathic hemolytic anemia,
neurologic deficits, renal abnormalities and fever.
Congenital deficiency of ADAMTS13 (Upshaw-Schulman Syndrome) is
characterized by ADAMTS13 enzymatic activity of 2-7% or normal.2 Modest
reductions in ADAMTS13 have been noted in a variety of conditions, such as
severe sepsis, disseminated intravascular coagulation, heparin-induced
thrombocytopenia, cardiac surgery and cirrhosis.
Procedure Overview
1.
2.
Cover the plate and incubate at room temperature (20-25C) for 1 hour.
3.
4.
8.
Ultrapure water
Precautions
Use new disposable pipette tips for each transfer to avoid crosscontamination.
Minimize lag time between wash steps to ensure the plate does not become
completely dry during the assay.
1.
2.
3.
Percentage
Standard
1X Dilution
Buffer B
1
2
3
4
100%
50%
25%
12.5%
0.3 ml
0.3 ml
0.3 ml
Preparation of Controls
1.
2.
Sample Handling
This ELISA assay has been validated for human plasma samples.
Sample Preparation
Assay Procedure
Sample Incubation
Determine the number of strips required. Leave these strips in the plate
frame. Place unused strips in the foil pouch with desiccant and seal tightly.
Store unused strips at 2-8C. After completing assay, keep the plate frame
for additional assays.
Use a Plate Template to record the locations of the standards, controls and
unknown samples within the wells.
1.
2.
Carefully cover the wells with a new adhesive plate cover and incubate for
one (1) hour at room temperature, 20-25C.
3.
Carefully remove the adhesive plate cover and wash FOUR times with 1X
Wash Buffer, as described in the Plate Washing section below.
Plate Washing
1.
Rinse the tips of the plate washer by dispensing the 1X Wash Buffer into
the wash trough and aspirating the solution. Repeat this step five times. For
automated plate washers, program the rinse step accordingly.
Note: This initial rinse step is necessary especially if the plate washer has
been idle for several days or longer. Automated plate washers are
susceptible to microbial growth in the fluid lines and cavities.
2.
Aspirate the solutions from the wells. Fill the wells to about 90% full with
1X Wash Buffer and then aspirate the wash solution. Repeat this wash step
three more times. For automated plate washers, program 4 washes at 300 l
per wash, according to the manufacturers instructions.
1.
Gently squeeze the long sides of plate frame before washing to ensure all
strips remain securely in the frame.
2.
Empty the plate contents by quickly dumping the contents of the wells into
the sink using a quick, flipping motion.
3.
Use a squirt wash bottle to fill each well completely with 1X Wash Buffer,
and then empty the plate contents. Repeat procedure three more times for a
total of FOUR washes. Blot the plate onto paper towels or other absorbent
material.
Only remove the required amount of Detection Antibody reagent for the
number of strips being used.
1.
2.
Carefully attach a new adhesive plate cover and incubate the plate for one
hour at room temperature, 20-25C.
3.
Carefully remove the adhesive plate cover, discard plate contents and wash
FOUR times with 1X Wash Buffer (see Plate Washing section above).
Remove only the required amount of HRP Solution A for the number of
strips being used.
1.
Add 100 l of HRP Solution A to each well containing standard, sample or blank.
2.
Carefully attach a new adhesive plate cover and incubate plate for 30
minutes at room temperature, 20-25C.
3.
Carefully remove the adhesive plate cover, discard plate contents and wash
FOUR times with 1X Wash Buffer (see Plate Washing section). Blot off
any residual liquid at the bottom of the wells that might interfere later with
the absorbance readings.
Remove only the required amount of TMB Substrate Solution and Stop
Solution for the number of strips being used.
Do NOT use glass pipette to measure the TMB Substrate Solution. Do NOT
cover the plate with aluminum foil or metalized mylar. Do NOT return
leftover TMB Substrate to bottle. Do NOT contaminate the unused TMB
Substrate Solution. If the solution is blue before use, DO NOT USE IT!
Bethyl Laboratories, Inc., www.bethyl.com
Telephone: 800-338-9579 Fax: 866-597-6105
8
1.
Add 100 l of TMB Substrate Solution into each well and allow the
enzymatic reaction to develop a blue color at room temperature (20-25C)
in the dark for 30 minutes. Do NOT cover plate with a plate sealer.
2.
Stop the reaction by adding 100 l of Stop Solution to each well. Tap plate
gently to mix. The solution in the wells should immediately change in color
from blue to yellow.
Absorbance Measurement
Note: Wipe the underside of the wells with a lint-free tissue.
1.
For end-point ELISA, measure the absorbance on an ELISA plate reader set
at 450 nm within 30 minutes after the addition of the Stop Solution.
Calculation of Results
1.
2.
3.
Performance Characteristics
Typical Standard Curve
This typical standard curve was generated using the Human ADAMTS13
ELISA Kit Protocol. This standard curve is for demonstration only. A
standard curve must be generated for each assay.
Suggested standard curve points are 100%, 50%, 25% and 12.5%, and 0%.
Specificity
Representative Data
Donor
2
Donor
3
Donor
4
Donor
5
Donor
6
65
109
97
70
85
82
Warranty
Products are warranted by Bethyl Laboratories, Inc. to meet stated product
specifications and to conform to label descriptions when used, handled and
stored according to instructions. Unless otherwise stated, this warranty is limited
to six months from date of sale. Bethyl Laboratories sole liability for the product
is limited to replacement of the product or refund of the purchase price. Bethyl
Laboratories products are supplied for research applications. They are not
intended for medicinal, diagnostic or therapeutic use. The products may not be
resold, modified for resale or used to manufacture commercial products without
prior written approval from Bethyl Laboratories, Inc.
Background References
1. Chan, et al., ADAMTS13 and von Willebrand factor and the risk of
myocardial infarction in men. Blood 109 (5):1998-2000, 2007.
2. Rose, BD. Causes of thrombotic thrombocytopenic purpura-hemolytic
uremic syndrome in adults. In: UpToDate, Leung, LK (ed), UpToDate,
Waltham, MA, 2008.
Rev 120112
Plate Templates
1
10
11
12
10
11
12
A
B
C
D
E
F
G
H
A
B
C
D
E
F
G
H